JPH0892057A - Cosmetic blended with extract of seed of coffee tree - Google Patents
Cosmetic blended with extract of seed of coffee treeInfo
- Publication number
- JPH0892057A JPH0892057A JP6248772A JP24877294A JPH0892057A JP H0892057 A JPH0892057 A JP H0892057A JP 6248772 A JP6248772 A JP 6248772A JP 24877294 A JP24877294 A JP 24877294A JP H0892057 A JPH0892057 A JP H0892057A
- Authority
- JP
- Japan
- Prior art keywords
- extract
- chlorogenic acid
- coffee tree
- hair
- cosmetic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Cosmetics (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Description
【0001】[0001]
【産業上の利用分野】本発明は、クロロゲン酸を必須成
分として含有するコーヒーノキ種子抽出物を配合する化
粧料に関するものである。その利用分野としては、医薬
品・医薬部外品或は化粧品分野(人及びその他の動物用
に用いる各種製剤)の各種化粧料用組成物として利用で
き、具体的には、ローション、乳液、クリーム(軟膏を
含む)、オイル、パック、石鹸(薬用石鹸も含む)、ボ
ディソープ、浴用剤、シャンプー、リンス、ヘアートニ
ック、ヘアースプレーなどへの応用が上げられる。BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a cosmetic composition containing a coffee tree seed extract containing chlorogenic acid as an essential component. It can be used as various cosmetic compositions in the fields of pharmaceuticals / quasi-drugs or cosmetics (various preparations used for humans and other animals). Specifically, lotions, emulsions, creams ( Applications include ointments), oils, packs, soaps (including medicated soaps), body soaps, bath agents, shampoos, rinses, hair nicks, hair sprays, etc.
【0002】[0002]
【従来の技術】皮膚や頭髪は生体の表面を覆い、劣悪な
環境、例えば、紫外線、細菌、埃など様々な要因から生
体を守っているものであり、言い換えれば、皮膚や頭髪
はそれらの環境因子に絶えずさらされ、傷ついている。2. Description of the Related Art The skin and hair cover the surface of the living body and protect the living body from various factors such as bad environment such as ultraviolet rays, bacteria and dust. In other words, the skin and hair are those environments. Constantly exposed to the factors and hurt.
【0003】従って、生体内外に悪影響を与える環境因
子より皮膚・頭髪を守り、又、傷ついた皮膚や頭髪の再
生を促す化粧品等の研究が古くより行われている。更
に、近年では健康面からの目的にとどまらず、常に美し
くありたいという心理を背景に、美容を目的とした研究
も盛んになされている。Therefore, research has been conducted for a long time for cosmetics and the like that protect skin and hair from environmental factors that have an adverse effect on the inside and outside of the body, and that promote regeneration of damaged skin and hair. Furthermore, in recent years, research aiming at beauty has been actively conducted, not only for the purpose of health, but also for the background of the psychology of always wanting to be beautiful.
【0004】又、生体内外に悪影響を与える因子の除去
・消去を目的とする医薬品や医薬部外品、化粧品が現
在、多種類に渡り上市されているが、これらの効果・作
用の中に、過酸化脂質生成抑制作用、紫外線吸収作用、
メラニン生成抑制作用等が知られている。[0004] In addition, many kinds of pharmaceuticals, quasi drugs, and cosmetics for the purpose of removing / eliminating factors adversely affecting the inside and outside of the living body are currently on the market, and among these effects / actions are: Lipid peroxide production inhibitory action, UV absorbing action,
The melanin production inhibitory action and the like are known.
【0005】例えば、過酸化脂質生成抑制作用は、生体
に存在する脂質(油分)が酸化されるのを防ぐ作用であ
る。脂質の酸化によりできた過酸化脂質は、生体内で細
胞膜機能に障害を与えたり、各種酵素の不活性化や蛋白
の変性などをきたし、生体組織に悪影響を与える。これ
らは老化や癌性変化などの疾病へつながるものとも考え
られ、近年においては、この脂質の過酸化を抑制するこ
とが医学上、重要視されている。[0005] For example, the lipid peroxide production inhibitory action is an action of preventing lipids (oils) existing in the living body from being oxidized. Lipid peroxide formed by oxidation of lipids impairs cell membrane function in the body, inactivates various enzymes, denatures proteins, etc., and adversely affects living tissues. These are also considered to lead to diseases such as aging and cancerous changes, and in recent years, suppression of this lipid peroxidation has been medically regarded as important.
【0006】又、太陽光紫外線は、人間にとって、ビタ
ミンDの合成、殺菌・消毒作用等、健康、衛生面で有用
性を持つが、反面、サンバーン、サンタン、皮膚の老
化、皮膚ガンの惹起と言った有害な作用をも持ち合わせ
ている。[0006] Further, sunlight and ultraviolet rays are useful for humans in terms of health and hygiene such as synthesis of vitamin D, sterilizing and disinfecting action, but on the other hand, they cause sunburn, suntan, skin aging, and skin cancer. It also has the said harmful effects.
【0007】一口に、紫外線と言っても、生物学的な作
用の違いによって、290nm以下のUV−C領域、2
90〜320nmのUV−B領域、320〜400nm
のUV−A領域の3領域に分けられており、UV−C領
域は生物に対する作用が強く発ガン性の高い紫外線であ
るが、成層圏にあるオゾン層によってほとんど吸収され
るため地上には到達しないとされているが、、近年オゾ
ン層の減少が問題になり、皮膚ガンの増加が懸念されて
いる。UV−B,A領域の紫外線もサンバーン(急性炎
症)やサンタン(色素沈着)、皮膚の老化、皮膚ガンの
発生等を促すが紫外線が皮膚に照射された場合、UV−
Bは角質層と表皮を透過し、約3〜6時間後に紅斑が現
れ、24時間後にピークに達する。そして4〜15日で
紅斑が徐々に黒化へと移行するが、これはメラノサイト
がUV−Bによる炎症反応により活性化され、メラニン
生成量の増加によるために起こるものである。又、損傷
を受けた表皮組織に於いて角化が進み、角質層水分量の
減少に伴う肌荒れを起こしてしまう。[0007] In a word, even if it is called ultraviolet rays, due to the difference in biological action, it is in the UV-C region of 290 nm or less, 2
90-320 nm UV-B region, 320-400 nm
It is divided into 3 regions of UV-A region, and UV-C region is an ultraviolet ray that has a strong effect on living organisms and is highly carcinogenic, but it does not reach the ground because it is almost absorbed by the ozone layer in the stratosphere. However, the decrease of the ozone layer has become a problem in recent years, and there is a concern that skin cancer will increase. UV rays in the UV-B and A areas also promote sunburn (acute inflammation), suntan (pigmentation), skin aging, skin cancer, etc., but when UV rays are applied to the skin, UV-
B penetrates the stratum corneum and epidermis, erythema appears after about 3 to 6 hours, and reaches a peak after 24 hours. Then, in 4 to 15 days, the erythema gradually shifts to blackening, which occurs because the melanocytes are activated by the inflammatory reaction by UV-B and the melanin production amount increases. In addition, keratinization progresses in the damaged epidermal tissue, causing rough skin due to a decrease in the water content of the stratum corneum.
【0008】又、UV−Aは真皮層まで到達し、即時黒
化を起こし短時間で消失するとされているが、これは既
存のメラニンが酸化されて一時的に黒くなるためと考え
られている。連続的に浴びると遅延性の黒化を生じ、紅
斑の出現はないかわりに、メラノサイトの活性化は著し
く、黒化度も強くなる。更に、皮膚浸透性が高いため真
皮組織の損傷が激しく、皮膚の弾力性を失い、深いしわ
を生じ、色も茶褐色を呈してしまうという結果を引き起
こし、生体外から受けるこれらの紫外線(UV−B領
域、UV−A領域)を防御することも必要である。[0008] Further, it is said that UV-A reaches the dermis layer, causes immediate blackening, and disappears in a short time. This is considered to be because existing melanin is temporarily oxidized and blackened. . With continuous exposure, delayed blackening occurs, and although erythema does not appear, melanocyte activation is remarkable and the degree of blackening becomes strong. Furthermore, since the skin permeability is high, the dermal tissue is severely damaged, the elasticity of the skin is lost, deep wrinkles are caused, and the color becomes dark brown. It is also necessary to protect the area, UV-A area).
【0009】更に、生体内では様々な酸化・還元に関わ
る酵素が存在しているが、その中に皮膚黒化の原因の一
つとして、例えば、チロシナーゼ酵素が上げられ、動・
植物の有する色素の変化(現象)との関係から、いくつ
かの代謝機構が考えられているが、その一つに、メラノ
サイトにおけるチロシナーゼ酵素が活性化することによ
って、チロシンが酸化され、ドーパキノンに変換し、更
に、それが酸化されてドーパクロム、5,6−ジヒドロ
キシインドールになり、これが重合し、最終的には黒色
のメラニンを生成することが知られている。よって、こ
のような生化学的な機序に基づいた皮膚の異常な黒化を
防ぐ物質が求められている。又、同様にメラニン色素の
生成に関与するチロシナーゼの活性化を阻害する物質も
求められている。Further, there are various enzymes involved in oxidation and reduction in the living body. Among them, as one of the causes of skin darkening, for example, tyrosinase enzyme is raised, and
Several metabolic mechanisms are considered in relation to the change (phenomenon) of pigments in plants. One of them is the activation of tyrosinase enzyme in melanocytes to oxidize tyrosine and convert it into dopaquinone. However, it is further known that it is oxidized to dopachrome, 5,6-dihydroxyindole, which is polymerized and finally produces black melanin. Therefore, there is a demand for a substance that prevents abnormal blackening of the skin based on such a biochemical mechanism. There is also a need for a substance that inhibits the activation of tyrosinase, which is also involved in the formation of melanin pigment.
【0010】一方、クロロゲン酸については、コーヒー
生豆より初めて工業的に単離されたものと言われ、その
豆種としては、アラビカ種よりロブスタ種の方がクロロ
ゲン酸含量が多いことが知られている。又、クロロゲン
酸は、その他広く植物に存在し、多くの双子葉植物の果
実、葉に含まれ、クロロゲン酸を含む植物を例示する
と、タバコ葉、ナシ葉、リンゴ果肉、サツマイモ、桑、
茶等が知られている。On the other hand, chlorogenic acid is said to have been industrially isolated from green coffee beans for the first time, and it is known that Robusta seeds have a higher chlorogenic acid content than Arabica seeds. ing. In addition, chlorogenic acid is widely present in other plants and is contained in fruits of many dicotyledons, leaves, and examples of plants containing chlorogenic acid are tobacco leaves, pear leaves, apple pulp, sweet potato, mulberry,
Tea etc. are known.
【0011】尚、クロロゲン酸の工業分野への応用に関
する報告は最近になって行われるようになり、刊行物と
しては、1:特開昭57−83250(キャンデーの製
造法として、砂糖と水飴を主材とするキャンデー材料に
クロロゲン酸を添加し、キャンデーの褐変化を防止)、
2:特開昭57−115147(糖類を含有する食品及
び飲料にクロロゲン酸、その他、物質を添加し、糖類の
カラメル化による褐変化を防止)、3:特開昭57−1
17566(同様にパプリカ色素にクロロゲン酸、その
他、物質を添加し、パプリカ色素の経時的退色を防
止)、4:特開昭58−138347(生コーヒー豆酵
素分解抽出物の食用天然抗酸化物質)、5:特開昭60
−192555(クロロゲン酸等を必須成分としてなる
抗アレルギー食品)、6:特開昭62−111671
(生コーヒー豆熱水抽出物の食品用天然抗酸剤)、7:
特表昭63−502349(胃や十二指腸の粘膜を損傷
するか、胃酸分泌を促進する食物、飲料或は薬剤の投与
の前或は投与時に、単離されたクロロゲン酸を投与し、
潰瘍の進行に対して胃の粘膜を保護)8:特開平02−
100600(食品に桑・茶抽出液を添加し、この食品
を遠赤外線放射作用及びエチレンガス吸着作用を有する
包装紙で包装後、低温で保存することにより、長時間の
鮮度保持及び食品表面の褐変防止)、9:特開平04−
27374(クロロゲン酸等及びビタミンC等を飲食物
に含有して、飲食品の加工、保存間における香気香味の
減少、変化、異味異臭の発生を抑制)、10:特開平04
−283501(切花の鮮度保持剤)、11:特開平06
−9603(ビタミンCの安定化法)等が報告されてい
る。Incidentally, a report on the application of chlorogenic acid to the industrial field has been recently made, and the publication is 1: JP-A-57-83250 (Sugar and starch syrup as a method for producing candy). Chlorogenic acid is added to the main ingredient candy to prevent browning of the candy),
2: JP-A-57-115147 (chlorogenic acid and other substances are added to foods and drinks containing saccharides to prevent browning due to caramelization of sugars).
17566 (Similarly, chlorogenic acid and other substances are added to the paprika pigment to prevent the fading of the paprika pigment over time) 4: JP-A-58-138347 (natural edible antioxidant substance of enzymatically decomposed coffee beans) 5: JP-A-60
-192555 (Anti-allergic food containing chlorogenic acid as an essential component), 6: JP-A-62-111671
(Natural anti-acid agent for hot water extract of green coffee beans), 7:
Table 63-502349 (Isolated chlorogenic acid is administered before or during the administration of food, beverage or drug that damages the mucous membrane of the stomach or duodenum or promotes gastric acid secretion,
Protecting gastric mucosa against progression of ulcer) 8: JP-A-02-
100600 (Mulberry / tea extract is added to food, this food is wrapped in wrapping paper having far-infrared radiation and ethylene gas adsorption, and stored at low temperature to maintain long-term freshness and browning of food surface. Prevention), 9: JP-A-04-
27374 (containing chlorogenic acid and vitamin C and the like in food and drink to suppress the reduction and change of aroma and flavor during the processing and storage of food and drink and the generation of off-flavors), 10: JP-A-04-04
-283501 (Cut flower freshness-retaining agent), 11: JP-A-06-06
-9603 (stabilization method of vitamin C) and the like have been reported.
【0012】[0012]
【発明が解決しようとする課題】クロロゲン酸の利用
は、上記に示した如く、ほとんどが飲食物の退色・褐変
化の防止、異味異臭の抑制、又、胃や十二指腸の粘膜の
保護、ビタミンCの安定化を目的としたものであり、作
用・効果も経口によって得られるものである。一方、化
粧料分野では有効に利用されたものは見当たらない。そ
こで、本発明者らはクロロゲン酸を高含有するコーヒー
ノキ種子抽出物の独自の新規、有用利用とその作用に関
する検討、追求を試み鋭意研究を進めてきた。As described above, most of the utilization of chlorogenic acid is to prevent fading and browning of foods and drinks, to suppress off-flavors, to protect mucous membranes of stomach and duodenum, and vitamin C. It is intended to stabilize the drug, and the action and effect can be obtained by oral administration. On the other hand, in the field of cosmetics, none has been effectively used. Therefore, the present inventors have conducted intensive studies to study and pursue the unique novel and useful utilization of coffee tree seed extract containing a high amount of chlorogenic acid and its action.
【0013】[0013]
【発明が解決するための手段】すなわち、本発明者ら
は、上記事情に鑑み、コーヒーノキの種子にクロロゲン
酸が多く含まれていることから、コーヒーノキの種子か
ら抽出して得られるクロロゲン酸含有抽出物を検討し、
前述の過酸化脂質生成抑制作用、紫外線吸収作用、メラ
ニン生成抑制作用を有することを確認し、化粧料に応用
することが非常に有効であることを発見し、本発明を完
成した。尚、以下に本発明に至る経過を説明する。In view of the above circumstances, the present inventors have found that coffee seeds contain a large amount of chlorogenic acid. Therefore, a chlorogenic acid-containing extract obtained by extracting coffee coffee seeds is obtained. Consider things,
The present invention was completed by confirming that it has the above-mentioned lipid peroxide production inhibitory action, ultraviolet ray absorption action, and melanin production inhibitory action, and found that it is extremely effective to apply it to cosmetics. The process leading to the present invention will be described below.
【0014】本発明のコーヒーノキは、コーヒーノキ属
アカネ科の熱帯アフリカ地方、主に、エチオピア原産の
常緑低木で、葉は長卵形でやや革質、周年開花し、花は
短い花柄をもって葉腋に群生する。花冠は基部が筒状、
先端が数片に分かれ、白い色で芳香がある。果実は小さ
な球形ないし楕円形で初め緑色、熟すにつれて紅色、紫
色になり、通常2個の種子を含む。この種子は、半球形
状で、平らな面に1本の深い溝があり、平豆と呼ばれ、
果実は開花後8〜9カ月で収穫・輸入されている。尚、
本発明においては、コーヒーノキ(Coffee arabica
L.)の種子から得られるものを用いるが、その他、同属
種のロブスタコーヒーノキ(Coffee canephora Pier
r.)やリベリアコーヒーノキ(Coffee liberica Bul
l.)の種子を用いることも可能である。The coffee tree of the present invention is an evergreen shrub native to the tropical African region of the Rubiaceae family, mainly in Ethiopia. The leaves are long-ovate, somewhat leathery, and bloom on year-round, and the flowers are clustered in axillary with a short floral pattern. To do. The base of the corolla is tubular,
The tip is divided into several pieces, with a white color and fragrance. The fruits are small spheres or ovals, initially green, reddish and purple with ripening and usually contain two seeds. This seed is hemispherical and has one deep groove on the flat surface, called flat bean,
Fruits are harvested and imported 8-9 months after flowering. still,
In the present invention, coffee arabica
L.) seeds are used, but in addition, coffee canephora Pier (Coffee canephora Pier)
r.) and Liberia coffee (Coffee liberica Bul)
It is also possible to use seeds of l.).
【0015】又、コーヒーノキの種子からの抽出は、こ
れらを生のまま、或は乾燥して粉砕後、溶媒として、有
機溶媒、水又は熱水、有機溶媒又は水との混合溶媒、更
に、有機溶媒抽出と水抽出とが組み合わされたものでも
良い。又、有機溶媒としてはメタノール、エタノール、
n−ブタノール、アセトン、クロロホルム、酢酸エチ
ル、n−ヘキサン、1,3−ブチレングリコール、プロ
ピレングリコール等が用いられる。Further, extraction of coffee tree seeds from the seeds of coffee trees is carried out raw or after drying and crushing, and as a solvent, an organic solvent, water or hot water, an organic solvent or a mixed solvent with water, and further an organic solvent. A combination of solvent extraction and water extraction may be used. Further, as the organic solvent, methanol, ethanol,
N-butanol, acetone, chloroform, ethyl acetate, n-hexane, 1,3-butylene glycol, propylene glycol and the like are used.
【0016】又、抽出条件は特に制限されるものはない
が、通常は常温及び加熱抽出が好ましい。抽出後は濾過
及び濃縮乾燥して、溶液状、ペースト状又は粉末状とし
て用ても良い。更に多くの場合は、そのままの状態で利
用できるが、必要ならば、その効力に影響のない範囲で
脱臭、脱色等の精製処理を加えても良い。尚、脱臭、脱
色等の精製処理手段としては、活性炭カラムなどを用い
れば良く、抽出物質により一般的に適用される通常の手
段を任意に選択して行えば良い。The extraction conditions are not particularly limited, but usually room temperature and heat extraction are preferred. After extraction, the solution may be filtered, concentrated and dried to be used as a solution, paste or powder. In many cases, it can be used as it is, but if necessary, purification treatments such as deodorization and decolorization may be added within a range that does not affect its efficacy. As a purification treatment means for deodorization, decolorization, etc., an activated carbon column or the like may be used, and any ordinary means generally applied depending on the extraction substance may be arbitrarily selected.
【0017】尚、本発明で必須成分としたクロロゲン酸
は、モノー及びジカフェオイルキナ酸(Caffeoylquinic
acid)及びその混合物を意味するが、3−,4−及び
5−カフェオイルキナ酸或はその混合物が好ましい。更
に、クロロゲン酸は遊離酸或は生理学的に受容可能な誘
導体の形、詳細には塩或はエステルの形でも良く、特
に、カリウム塩(カリウムカフェイン等)が適してい
る。Chlorogenic acid, which is an essential component of the present invention, includes mono- and dicaffeoylquinic acid (Caffeoylquinic acid).
acid) and mixtures thereof, with preference given to 3-, 4- and 5-caffeoylquinic acid or mixtures thereof. Further, chlorogenic acid may be in the form of a free acid or a physiologically acceptable derivative, in particular a salt or an ester form, and a potassium salt (potassium caffeine etc.) is particularly suitable.
【0018】本発明のクロロゲン酸を必須成分として含
有するコーヒーノキ種子抽出物は、そのままでも利用で
きるが、化粧料として配合される場合の処方量は、化粧
料の種類、用いる抽出物の品質、期待される作用の程度
によって若干異なる。通常、0.05〜30重量%(以
下、重量%で表わす)、好ましくは、3〜10%が良
い。尚、配合量が0.05%より少ないと効果が充分で
なく、又、30%を越えて配合しても、その量に見合う
だけの効果が期待出来ない。The coffee tree seed extract containing chlorogenic acid of the present invention as an essential component can be used as it is, but when it is blended as a cosmetic, the amount to be prescribed depends on the kind of the cosmetic, the quality of the extract used, and the expectation. Slightly different depending on the degree of action taken. Usually, 0.05 to 30% by weight (hereinafter, represented by% by weight), preferably 3 to 10% is good. If the amount is less than 0.05%, the effect is not sufficient, and even if the amount exceeds 30%, the effect commensurate with the amount cannot be expected.
【0019】尚、本発明のクロロゲン酸を必須成分とし
て含有するコーヒーノキ種子抽出物を配合した化粧料に
は、本発明の効果を損なわない範囲内で、化粧品、医薬
品、医薬部外品等に一般的に用いられる各種成分、例え
ば、油分(動植物油、鉱物油、エステル油、ワックス
油、シリコン油、高級アルコール、リン脂質類、脂肪酸
類等)、界面活性剤(アニオン性、カチオン性、両性又
は非イオン性界面活性剤)、ビタミン類(ビタミンA
群、ビタミンB群、葉酸類、ニコチン酸類、パントテン
酸類、ビオチン類、ビタミンC群、ビタミンD群、ビタ
ミンE群、その他フェルラ酸、γ−オリザノール等)、
紫外線吸収剤(p−アミノ安息香酸、アントラニル、サ
ルチル酸、クマリン、ベンゾトリアゾール、テトラゾー
ル、イミダゾリン、ピリミジン、ジオキサン、フラン、
ピロン、カンファー、核酸、アラントイン及びそれらの
誘導体、アミノ酸系化合物、シコニン、バイカリン、バ
イカレイン、ベルベリン等)、抗酸化剤(ステアリン酸
エステル、ノルジヒドログアセレテン酸、ジブチルヒド
ロキシトルエン、ブチルヒドロキシアニソール、パラヒ
ドロキシアニソール、没食子酸プロピル、セサモール、
セサモリン、ゴシポール等)、増粘剤(ヒドキシエチル
セルロース、エチルセルロース、カルボキシエチルセル
ロース、メチルセルロース、カルボキシメチルセルロー
ス、カルボキシメチルセルロースナトリウム、ヒドキシ
プロピルセルロース、ニトロセルロース、ポリビニルア
ルコール、ポリビニルメチルエーテル、ポリビニルピロ
リドン、ポリビニルメタアクリレート、ポリアクリル酸
塩、カルボキシビニルポリマー、アラビアゴム、トラガ
ントゴム、寒天、カゼイン、デキストリン、ゼラチン、
ペクチン、デンプン、アルギン酸及びその塩等)、保湿
剤(プロピレングリコール、1,3−ブチレングリコー
ル、ポリエチレングリコール、グリセリン、コンドロイ
チン硫酸及びその塩、ヒアルロン酸及びその塩、乳酸ナ
トリウム等)又、その他、低級アルコール、多価アルコ
ール、水溶性高分子、pH調整剤、防腐・防バイ剤、着
色料、香料、清涼剤、安定化剤、動・植物抽出物、動・
植物性蛋白質及びその分解物、動・植物性多糖類及びそ
の分解物、動・植物性糖蛋白質及びその分解物、微生物
培養代謝成分、血流促進剤、消炎剤、抗炎症剤、抗アレ
ルギー剤、細胞賦活剤、アミノ酸及びその塩、角質溶解
剤、収斂剤、創傷治療剤、増泡剤、口腔用剤、消臭・脱
臭剤と共に配合し、併用して用いることも出来る。The cosmetics containing the coffee tree seed extract containing chlorogenic acid as an essential component of the present invention are generally used in cosmetics, pharmaceuticals, quasi drugs, etc. within a range not impairing the effects of the present invention. Various components commonly used, such as oils (animal and vegetable oils, mineral oils, ester oils, wax oils, silicone oils, higher alcohols, phospholipids, fatty acids, etc.), surfactants (anionic, cationic, amphoteric or amphoteric Nonionic surfactant), vitamins (vitamin A)
Group, vitamin B group, folic acid, nicotinic acid, pantothenic acid, biotin, vitamin C group, vitamin D group, vitamin E group, other ferulic acid, γ-oryzanol, etc.),
UV absorbers (p-aminobenzoic acid, anthranil, salicylic acid, coumarin, benzotriazole, tetrazole, imidazoline, pyrimidine, dioxane, furan,
Pyrone, camphor, nucleic acid, allantoin and their derivatives, amino acid compounds, shikonin, baicalin, baicalein, berberine, etc., antioxidants (stearate, nordihydroguaselethenoic acid, dibutylhydroxytoluene, butylhydroxyanisole, para) Hydroxyanisole, propyl gallate, sesamol,
Sesamolin, gossypol, etc.), thickener (hydroxyethyl cellulose, ethyl cellulose, carboxyethyl cellulose, methyl cellulose, carboxymethyl cellulose, carboxymethyl cellulose sodium, hydroxypropyl cellulose, nitrocellulose, polyvinyl alcohol, polyvinyl methyl ether, polyvinyl pyrrolidone, polyvinyl methacrylate, Polyacrylate, carboxyvinyl polymer, gum arabic, gum tragacanth, agar, casein, dextrin, gelatin,
Pectin, starch, alginic acid and its salts), moisturizers (propylene glycol, 1,3-butylene glycol, polyethylene glycol, glycerin, chondroitin sulfate and its salts, hyaluronic acid and its salts, sodium lactate, etc.) Alcohol, polyhydric alcohol, water-soluble polymer, pH adjuster, antiseptic / antifungal agent, colorant, fragrance, cooling agent, stabilizer, animal / plant extract, animal / animal
Vegetable protein and its degradation product, animal / vegetable polysaccharide and its degradation product, animal / vegetable glycoprotein and its degradation product, microbial culture metabolic component, blood flow promoter, anti-inflammatory agent, anti-inflammatory agent, anti-allergic agent , A cell activating agent, an amino acid and its salt, a keratolytic agent, an astringent agent, a wound healing agent, a foaming agent, an oral agent, and a deodorant / deodorant, and they can be used together.
【0020】又、本発明のクロロゲン酸を必須成分とし
て含有するコーヒーノキ種子抽出物を配合した化粧料の
剤型については、任意であり、常法により配合し、例え
ば、化粧水、クリーム、軟膏、ローション、乳液、パッ
ク、オイル、石鹸(薬用石鹸も含む)、洗顔料、香料、
オーデコロン、浴用剤、シャンプー、リンス、ヘアート
ニック、ヘアースプレー等の形態とすることが出来る。
その他、各種形態の経口薬剤、更に衛生綿類、ウエット
ティシュ等の不織布に、又、口内炎等による口腔用組成
物としても利用可能である。The dosage form of the cosmetic composition containing the coffee tree seed extract containing chlorogenic acid of the present invention as an essential component is arbitrary, and may be prepared by a conventional method, for example, a lotion, cream, ointment, Lotion, emulsion, pack, oil, soap (including medicated soap), face wash, fragrance,
It can be in the form of cologne, bath agent, shampoo, conditioner, hairnic, hair spray and the like.
In addition, various forms of oral drugs, non-woven fabrics such as sanitary cotton and wet tissues, and oral compositions due to stomatitis can be used.
【0021】更に、化粧料の形態は、任意であり、溶液
状、クリーム状、ペースト状、ゲル状、ジェル状、泡
状、固形状又は粉末状として用いることが出来る。Further, the form of the cosmetic is arbitrary, and it can be used in the form of solution, cream, paste, gel, gel, foam, solid or powder.
【0022】以下に、製造例(抽出例)を開示し、より
詳しく述べるが、以下によって示される方法は、後述の
作用等の確認試験において用いたものであり、これに限
定されるものではない。The production examples (extraction examples) will be disclosed and described in more detail below, but the method shown by the following is used in the confirmation test of the action and the like described later, and is not limited to this. .
【0023】抽出例1:(1,3−ブチレングリコール
による抽出) コーヒーノキの種子(生豆)20gを微粉砕し、60%
1,3−ブチレングリコール水溶液(1Kg)を加え、7
5℃にて3時間攪拌抽出し、冷却後、濾過して固・液分
離を行い、分離した抽出液を陽イオン交換樹脂250m
lを充填したカラムに通液し、カフェインを吸着した
後、溶出液を減圧乾固して、本発明のコーヒーノキ種子
抽出物を約2.5gを得る。次に0.5gを取り、20
%1,3−ブチレングリコール水溶液を加えて溶解さ
せ、コーヒーノキ種子抽出液を100mlとした。Extraction Example 1: (Extraction with 1,3-butylene glycol) 20 g of coffee tree seeds (green beans) were pulverized to 60%
Add 1,3-butylene glycol aqueous solution (1Kg),
The mixture is stirred and extracted at 5 ° C for 3 hours, cooled, filtered, and then solid-liquid separated.
After passing through a column filled with 1 to adsorb caffeine, the eluate is dried under reduced pressure to obtain about 2.5 g of the coffee tree seed extract of the present invention. Then take 0.5g, 20
% 1,3-butylene glycol aqueous solution was added and dissolved to make 100 ml of the coffee tree seed extract.
【0024】抽出例2:(エタノールによる抽出) コーヒーノキの種子(生豆)20gを粉砕して、60%
エタノール水溶液(1Kg)を加え、75℃にて3時間攪
拌抽出し、冷却後、濾過して固・液分離を行い、分離し
た抽出液を減圧濃縮して、エタノール除去後、コーヒー
ノキ種子抽出液を約40mlを得た。Extraction Example 2: (Extraction with ethanol) 20 g of coffee tree seeds (green beans) were crushed to 60%
Aqueous ethanol solution (1Kg) was added, and the mixture was extracted with stirring at 75 ° C for 3 hours, cooled, filtered and subjected to solid / liquid separation, and the separated extract was concentrated under reduced pressure to remove ethanol and then extract the coffee tree seed extract. About 40 ml was obtained.
【0025】抽出例3:(熱水による抽出) コーヒーノキの種子(生豆)20gを粉砕して、水(1K
g)を加え、75℃にて3時間攪拌抽出し、冷却後、濾
過して固・液分離を行い、分離した抽出液を減圧濃縮し
て、コーヒーノキ種子抽出液を約40mlを得た。Extraction Example 3: (Extraction with hot water) 20 g of coffee tree seeds (green beans) were crushed into water (1 K).
g) was added, and the mixture was stirred and extracted at 75 ° C. for 3 hours, cooled, filtered and subjected to solid / liquid separation, and the separated extract was concentrated under reduced pressure to obtain about 40 ml of a coffee tree seed extract.
【0026】[0026]
【実施例】以下に、実施例等を開示し、より詳しく述べ
るが、以下によって示される方法は、後述の作用等の確
認試験において用いたものであり、これに限定されるも
のではない。[Examples] Examples will be disclosed and described in more detail below, but the method shown below was used in the confirmation test for the action and the like described later, and is not limited thereto.
【0027】実施例1:クロロゲン酸の定量 クロロゲン酸(ジャンセン製)粉末をエタノール溶液に
溶解した液を標品とし上記で得られた抽出例1〜3のク
ロロゲン酸含有量を高速液体クロマトグラフィー(島津
製作所製)によって測定した。試験結果は下記に示し
た。 抽出例1:(1,3−ブチレングリコールによる抽出
液) クロロゲン酸含有量:3.8% 抽出例2:(エタノールによる抽出液) クロロゲン酸含有量:2.6% 抽出例3:(熱水による抽出液) クロロゲン酸含有量:2.4%Example 1 Determination of Chlorogenic Acid Chlorogenic acid (manufactured by Janssen) was dissolved in an ethanol solution as a standard and the chlorogenic acid contents of Extraction Examples 1 to 3 obtained above were analyzed by high performance liquid chromatography ( It was measured by Shimadzu Corporation. The test results are shown below. Extraction example 1: (Extract with 1,3-butylene glycol) Chlorogenic acid content: 3.8% Extraction example 2: (Extract with ethanol) Chlorogenic acid content: 2.6% Extraction example 3: (Hot water Extraction solution) Chlorogenic acid content: 2.4%
【0028】実施例2:過酸化脂質生成抑制作用試験 TBA法(アナリティカル、ハ゛イオケミストリーカル Vol.95、p.351〜358、1
979)をもとに、リノレン酸の過酸化物生成抑制作用を
検討し、以下の試験方法で測定した。Example 2 Lipid Peroxide Production Inhibitory Action Test TBA method (Analytical, Biochemistry Vol.95, p.351-358, 1)
979), the inhibitory effect of linolenic acid on peroxide generation was examined and measured by the following test method.
【0029】「試験方法」0.8%ラウリル硫酸ナトリ
ウム水溶液にリノレン酸0.1%を加え溶解し、この溶
液3.9mlを10mlの透明なガラススクリュー瓶に
とる。これに検体溶液0.1mlを加え、紫外線(東芝
製:FL-20SEランプ及びFL-20SBLランプをそれぞれ3灯並
列して距離15cmにて照射)を1時間照射した後、こ
の液1mlを取り、0.67%チオバルビツール酸水溶
液と15%酢酸水溶液(pH3.5)の混液を1ml、
4.5%ジブチルヒドロキシトルエン20μlを加え、
95℃で1時間加熱する。冷却後、メタノール:n−ブ
タノール(15:85)4mlを加え良く振った後、遠心分
離する。次に、このn−ブタノール層の534nmにお
ける吸光度を測定し、過酸化脂質量とした。尚、検体を
加えて紫外線を照射した場合の過酸化脂質量をa、検体
を加えて紫外線を照射していない場合の過酸化脂質量を
b、検体の代わりに抽出溶媒(1,3−ブチレングリコ
ール又はエタノール、精製水)を加えて紫外線を照射し
た場合の過酸化脂質量をa’、検体の代わりに抽出溶媒
(1,3−ブチレングリコール又はエタノール、精製
水)を加えて紫外線を照射しない場合の過酸化脂質量を
b’として、過酸化脂質生成抑制率を数1により求め
た。 「検体の調整」検体としては、上記に示した抽出例1〜
3を用い、対照として、比較例1:α−トコフェロール
(キシダ化学製)1gをエタノール溶液100mlに溶
解させた液を用いた。[Test Method] 0.1% linolenic acid was added to 0.8% sodium lauryl sulfate aqueous solution and dissolved, and 3.9 ml of this solution was placed in a 10 ml transparent glass screw bottle. 0.1 ml of the sample solution was added to this, and ultraviolet rays (Toshiba: 3 FL-20SE lamps and 3 FL-20SBL lamps were lit in parallel at a distance of 15 cm) were irradiated for 1 hour, and 1 ml of this solution was taken. 1 ml of a mixture of 0.67% thiobarbituric acid aqueous solution and 15% acetic acid aqueous solution (pH 3.5),
Add 20 μl of 4.5% dibutyl hydroxytoluene,
Heat at 95 ° C. for 1 hour. After cooling, add 4 ml of methanol: n-butanol (15:85), shake well, and centrifuge. Next, the absorbance at 534 nm of this n-butanol layer was measured and used as the amount of lipid peroxide. The amount of lipid peroxide when the sample was added and irradiated with ultraviolet light was a, the amount of lipid peroxide when the sample was added and not irradiated with ultraviolet light was b, and the extraction solvent (1,3-butylene) was used instead of the sample. Glycol or ethanol, purified water) is added and the amount of lipid peroxide when irradiated with ultraviolet rays is a ', and the extraction solvent (1,3-butylene glycol or ethanol, purified water) is added instead of the sample and ultraviolet rays are not irradiated. When the lipid peroxide amount in this case was b ′, the lipid peroxide production inhibitory rate was calculated by Equation 1. As the “preparation of sample” sample, the above-mentioned extraction examples 1 to
As Comparative Example 3, 1 g of α-tocopherol (manufactured by Kishida Chemical Co., Ltd.) was dissolved in 100 ml of an ethanol solution and used as a control.
【0030】[0030]
【数1】 [Equation 1]
【0031】[0031]
【表1】 [Table 1]
【0032】「試験結果」結果は表1の如く、本発明の
クロロゲン酸を必須成分として含有するコーヒーノキ種
子抽出物は、比較例1のトコフェロール溶液よりも若干
強いか、又は、ほぼ同等の過酸化脂質生成抑制作用を示
すことが確認出来た。[Test Results] The results are shown in Table 1. The coffee tree seed extract containing chlorogenic acid of the present invention as an essential component is slightly stronger than the tocopherol solution of Comparative Example 1 or has substantially the same peroxidation. It was confirmed that it exhibited a lipogenesis inhibitory action.
【0033】実施例3:紫外線吸収作用試験 「試験方法」分光光度計(1cm層長:石英セル)を用
いて、吸光度測定法により紫外線の吸光度を測定し、紫
外線吸収作用とした。尚、検体は実施例2の抽出例1ー
2をを用い、対照として同濃度のパラアミノ安息香酸
(PABA)を用いた。Example 3: Ultraviolet absorption test "Test method" Using a spectrophotometer (1 cm layer length: quartz cell), the absorbance of ultraviolet rays was measured by the absorbance measurement method to determine the ultraviolet absorption effect. The samples used were Extraction Examples 1-2 of Example 2, and the same concentration of para-aminobenzoic acid (PABA) was used as a control.
【0034】[0034]
【図1】[Figure 1]
【0035】「試験結果」結果は図1に示す如く、本発
明のクロロゲン酸を必須成分として含有するコーヒーノ
キ種子抽出物は、パラアミノ安息香酸に比べ、紫外線波
長(280〜350nm)を優位に吸収することが確認
出来た。[Test Results] As shown in FIG. 1, the coffee tree seed extract containing chlorogenic acid of the present invention as an essential component absorbs ultraviolet light wavelength (280 to 350 nm) predominantly as compared with para-aminobenzoic acid. I was able to confirm that.
【0036】実施例4:チロシナーゼ活性阻害作用試験 「試験方法」チロシン溶液(L−チロシン0.3mg/
ml)1.0ml、マックルバイン緩衝液(pH6.
5)2.0ml及び検体溶液を0.2mlを混合して、
37℃恒温槽中で、約10分間放置した後、これにチロ
シナーゼ溶液(マッシュルーム由来、2500unit
/ml)0.1mlを加えた後、475nmの吸光度を
測定(A)し、その後、この反応液を37℃恒温槽中
で、20分間放置後、同様に、475nmの吸光度を測
定する(A’)。又、同時にブランクとして、検体の代
わりに抽出溶媒(1,3−ブチレングリコール又はエタ
ノール、精製水)を加えて、同様な操作で吸光度を測定
(a)、(a’)して、チロシナーゼ活性阻害率を数2
により求めた。尚、検体は実施例1の抽出例1〜3及び
対照:比較例1を用いた。Example 4: Tyrosinase activity inhibitory activity test "Test method" tyrosine solution (L-tyrosine 0.3 mg /
1.0 ml, Macklevine buffer (pH 6.
5) Mix 2.0 ml and 0.2 ml of the sample solution,
After leaving for about 10 minutes in a 37 ° C constant temperature bath, add a tyrosinase solution (derived from mushrooms, 2500 unit
/ Ml) 0.1 ml was added, and then the absorbance at 475 nm was measured (A). After that, this reaction solution was allowed to stand for 20 minutes in a 37 ° C. constant temperature bath, and then the absorbance at 475 nm was similarly measured (A). '). At the same time, as a blank, an extraction solvent (1,3-butylene glycol or ethanol, purified water) was added instead of the sample, and the absorbance was measured (a) and (a ') by the same operation to inhibit tyrosinase activity. Rate 2
Sought by. The samples used were Extraction Examples 1 to 3 of Example 1 and Control: Comparative Example 1.
【0037】[0037]
【数2】 [Equation 2]
【0038】[0038]
【表2】 [Table 2]
【0039】「試験結果」結果は表2の如く、本発明の
クロロゲン酸を必須成分として含有するコーヒーノキ種
子抽出物は、比較例1のトコフェロール溶解液に比べ、
強いチロシナーゼ活性阻害作用を有することが確認出来
た。[Test Results] As shown in Table 2, the coffee tree seed extract containing chlorogenic acid of the present invention as an essential component was compared with the tocopherol solution of Comparative Example 1.
It was confirmed to have a strong tyrosinase activity inhibitory action.
【0040】実施例5:メラニン生成抑制作用試験 「試験方法」釈ら1)の方法(粧技誌 26(1),8,1992)を
参照し、C57BLマウス(8W♀)に紫外線(東芝製:紫
外線 FL20-SEランプ)を15.2mJ/cm2、1日1
回、3日間連続照射した。最終照射日より1週間後に耳
介を採取し、軟骨を除去後、外耳の皮膚を2N−臭化ナ
トリウム溶液に浸漬した。その後、表皮を直皮から剥離
し、この表皮を0.1%L−ドーパ溶液(0.1Mリン
酸緩衝液、pH7.2)に浸漬して、ドーパ染色を行っ
た。尚、検体(抽出例1〜3)はドーパ溶液中に、表3
に示す各濃度になるように添加し、対照としては20%
1,3−ブチレングリコール水溶液を同様に添加して行
い、判定は一定部分(5mm2)のメラノサイト数を顕微
鏡にて計測、1mm2当りの細胞数で評価し、結果は表
3に示した。Example 5: Melanin production inhibitory action test Referring to the method described in "Test method" (1) (Cosmetics Technical Journal 26 (1), 8, 1992), C57BL mice (8W♀) were exposed to ultraviolet rays (made by Toshiba). : UV FL20-SE lamp) 15.2 mJ / cm 2 , 1 day
Irradiation was repeated once for 3 days. One week after the final irradiation day, the auricle was collected, the cartilage was removed, and the skin of the outer ear was dipped in a 2N-sodium bromide solution. Then, the epidermis was peeled off from the direct skin, and the epidermis was immersed in a 0.1% L-dopa solution (0.1 M phosphate buffer, pH 7.2) for dopa staining. The samples (Extraction Examples 1 to 3) were placed in the dopa solution as shown in Table 3.
20% as a control
A 1,3-butylene glycol aqueous solution was added in the same manner, and the determination was performed by measuring the number of melanocytes in a certain portion (5 mm 2 ) with a microscope and evaluating the number of cells per 1 mm 2 , and the results are shown in Table 3.
【0041】[0041]
【表3】 [Table 3]
【0042】「試験結果」結果は表3の如く、本発明の
クロロゲン酸を必須成分として含有するコーヒーノキの
種子抽出物は、紫外線により活性化された有色マウス耳
介の表皮のメラノサイトを、ドーパ液で特異的に染色し
たところ、メラノサイト(メラニン生成細胞)数の減少
が優位に認められた。よって、メラニン生成抑制作用を
有することが確認出来た。[Test Results] The results are shown in Table 3, and the coffee tree seed extract containing chlorogenic acid of the present invention as an essential component was prepared by treating the melanocytes of the epidermis of colored mouse auricles activated by ultraviolet rays with dopa liquid. When specifically stained with, the decrease in the number of melanocytes (melanocytes) was predominantly observed. Therefore, it was confirmed that it has a melanin production inhibitory action.
【0043】実施例6:引張強度試験 「試験方法及び評価方法」未処理人毛50本を、温湯で
すすぎ洗い流し、検体溶液に未処理人毛50本を10分
間浸透させた後、良く風乾し、紫外線(東芝製:FL-20SE
ランプ及びFL-20SBLランプをそれぞれ3灯並列して距離
15cmにて照射)を1時間照射し、最後に温湯ですす
ぎ洗い流し、10分間乾燥して、引張強度を測定した。
測定に当っては、約10cmの長さを揃えた未処理人毛
を2cm/分の速度で1本づつ引っ張り、破断時の荷重
を求める方法により行った。尚、検体は実施例1の抽出
例1〜3及び比較例1を用い、引張強度の測定は、テン
シロンメーター(東洋ボールドウイン製)を使用し、条
件:温度20℃、湿度60%で評価した。表中の数値は
平均値を表し、結果を表4に示した。Example 6: Tensile Strength Test "Testing Method and Evaluation Method" Fifty untreated human hairs were rinsed with warm water, 50 untreated human hairs were allowed to penetrate into the sample solution for 10 minutes, and then air-dried well. , UV (Toshiba: FL-20SE
Three lamps and three FL-20SBL lamps were arranged in parallel and irradiated at a distance of 15 cm) for 1 hour, finally rinsed with warm water, rinsed off, and dried for 10 minutes to measure tensile strength.
In the measurement, untreated human hair having a uniform length of about 10 cm was pulled one by one at a speed of 2 cm / min, and the load at break was determined. The samples used were Extraction Examples 1 to 3 and Comparative Example 1 of Example 1, and the tensile strength was measured using a tensilon meter (manufactured by Toyo Baldwin) under the conditions of temperature 20 ° C. and humidity 60%. . Numerical values in the table represent average values, and the results are shown in Table 4.
【0044】[0044]
【表4】 [Table 4]
【0045】「試験結果」結果は表4の如く、本発明の
クロロゲン酸を必須成分として含有するコーヒーノキ種
子抽出物が添加処理された人毛は、比較例1(α-トコフェロー
ル溶解液)添加処理人毛に比べ、破断荷重が高い数値を示
し、紫外線による毛髪の引張強度の低下を抑制する保護
作用を有する、良好な結果が得られた。[Test Results] As shown in Table 4, the human hair treated with the coffee tree seed extract containing chlorogenic acid of the present invention as an essential component was treated with Comparative Example 1 (α-tocopherol solution). As compared with human hair, the breaking load showed a higher numerical value, and good results were obtained with a protective effect of suppressing the decrease in the tensile strength of hair due to ultraviolet rays.
【0046】実施例7:水分保持効果の持続性 「試験方法及び評価方法」人毛(重さ4g、長さ10c
m)に、下記表5に示したヘアリンスを5g塗布し、温
湯ですすぎ洗い流し、10分間風乾した後、一定湿度下
に保存し、直後と3時間後の含水率を測定し、変化率を
求めて効果の持続性を評価した。尚、評価方法は次のA
−Cの3段階評価にて行い、結果を表5に示した。 評価A:変化率50%未満。 評価B:変化率50%以上、70%未満。 評価C:変化率70%以上。Example 7: Persistence of water retention effect "Test method and evaluation method" Human hair (weight: 4 g, length: 10 c)
To m), apply 5 g of the hair rinse shown in Table 5 below, rinse with warm water, rinse with air for 10 minutes, store at constant humidity, and measure the water content immediately after and after 3 hours to obtain the change rate. The sustainability of the effect was evaluated. The evaluation method is
The results were shown in Table 5 by performing a 3-level evaluation of -C. Evaluation A: Change rate of less than 50%. Evaluation B: Change rate of 50% or more and less than 70%. Evaluation C: Change rate of 70% or more.
【0047】実施例8:感触官能試験(滑らかさ・しっ
とり感・くし通り性) 「試験方法及び評価方法」女性パネラー40名を各区1
0名づつ4区に分けて、下記表5に示した本発明品及び
比較品のヘアリンスを5g渡し、市販シャンプーで洗髪
し、温湯で良くすすぎ洗い流した後、実際に、頭髪に直
接各々のヘアリンスを塗布し、良く浸透させた後、温湯
ですすぎ洗い流し、風乾した後の滑らかさ、しっとり
感、くし通り性について官能評価を加えた。尚、評価方
法は次の1〜3の3段階評価にて行い、10名の平均値
を測り、結果を表5に示した。 評価3:良好。 評価2:普通。 評価1:悪い。Example 8 Tactile sensory test (smoothness / moistness / combability) "Testing method and evaluation method" 40 female panelists, 1 in each section
The hair rinses of the present invention product and the comparative product shown in Table 5 below were handed over 5 g each by 0 people, washed with a commercial shampoo, rinsed well with warm water, and then rinsed with hair directly. Was applied and thoroughly permeated, rinsed with warm water, rinsed off, and sensory-evaluated for smoothness after air-drying, moist feeling, and combability. In addition, the evaluation method was performed by the following three-stage evaluation of 1 to 3, and the average value of 10 persons was measured, and the results are shown in Table 5. Evaluation 3: Good. Evaluation 2: Normal. Evaluation 1: Bad.
【0048】実施例9:感触官能試験(毛髪のつや) 「試験方法及び評価方法」女性パネラー40名を各区1
0名づつ4区に分けて、下記表5に示した本発明品及び
比較品のヘアリンスを5g渡し、市販シャンプーで洗髪
し、温湯で良くすすぎ洗い流した後、実際に、頭髪に直
接各々のヘアリンスを塗布し、良く浸透させた後、温湯
ですすぎ洗い流し、風乾した後の毛髪のつやについて官
能評価を加えた。尚、評価方法は次の1〜3の3段階評
価にて行い、10名の平均値を測り、結果を表5に示し
た。 評価3:つやがある。 評価2:ややつやがある。 評価1:つやがない。Example 9: Feeling sensory test (luster of hair) "Test method and evaluation method" 40 female panelists, 1 in each section
The hair rinses of the present invention product and the comparative product shown in Table 5 below were handed over 5 g each by 0 people, washed with a commercial shampoo, rinsed well with warm water, and then rinsed with hair directly. Was applied, thoroughly permeated, rinsed with warm water, rinsed, and air-dried, and a sensory evaluation was made on the gloss of the hair. In addition, the evaluation method was performed by the following three-stage evaluation of 1 to 3, and the average value of 10 persons was measured, and the results are shown in Table 5. Evaluation 3: Shiny. Evaluation 2: There is a gloss. Evaluation 1: Matte.
【0049】「試験結果」表5の配合組成からなるヘア
リンスを調製し、毛髪の水分保持効果の持続性、毛髪の
滑らかさ、しっとり感、くし通り性、毛髪のつやを比較
品と共に評価した。結果は表5の如く、本発明品1〜3
は、引張強度、毛髪の水分保持の持続性、毛髪の滑らか
さ、しっとり感、くし通り、つや、共に比較品に比べ、
総合的に良好な結果が得られた。"Test Results" Hair rinses having the composition shown in Table 5 were prepared, and the durability of the water retention effect of the hair, the smoothness of the hair, the moist feeling, the combability, and the gloss of the hair were evaluated together with the comparative product. The results are shown in Table 5 and shown in Tables 1 to 3 of the present invention.
Is the tensile strength, the retention of moisture on the hair, the smoothness of the hair, the moist feeling, the comb-through, the gloss, both of which are compared to the comparative product.
Overall, good results were obtained.
【0050】[0050]
【表5】 [Table 5]
【0051】実施例10:使用効果試験 「試験方法及び評価方法」成人男女パネラー40名を各
区10名づつ4区に分けて、下記表6に示した本発明品
及び比較品のサンスクリーン乳液を30g渡し、毎日、
外出する前に必ず手に適量を取り、顔に塗布してもら
い、1ケ月間に渡って連続使用効果試験を実施した。
尚、汗をかいたりして、洗顔した場合は、その都度、適
量を取り、塗布してもらった。評価方法は次の基準にて
行った。 「皮膚老化防止効果」 有 効:肌のはり、つやが改善された。 やや有効:肌のはり、つやがやや改善された。 無 効:使用前と変化なし。 「肌荒れ改善効果」 有 効:肌のかさつきや荒れが改善された。 やや有効:肌のかさつきや荒れがやや改善された。 無 効:使用前と変化なし。 「肌色改善効果」 有 効:肌の色が白く改善された。 やや有効:肌の色が若干白く改善された。 無 効:使用前と変化なし。 表7中の数値は人数を表し、結果を表7に示した。Example 10: Use effect test "Test method and evaluation method" 40 adult male and female panelists were divided into 4 groups with 10 groups each, and the sunscreen emulsions of the present invention and comparative products shown in Table 6 below were prepared. 30g handed every day,
Before going out, I took an appropriate amount by hand, applied it on my face, and conducted a continuous use effect test for one month.
When the face was washed by sweating, an appropriate amount was taken and applied each time. The evaluation method was based on the following criteria. "Skin aging prevention effect" Effective: The skin's suppleness and gloss were improved. Slightly effective: The skin's elasticity and gloss were slightly improved. Ineffective: No change from before use. "Effect of rough skin improvement" Effective: The roughness and roughness of the skin were improved. Slightly effective: The bulkiness and roughness of the skin are slightly improved. Ineffective: No change from before use. "Skin color improvement effect" Effective: The skin color was improved to white. Slightly effective: The skin color was improved to be slightly white. Ineffective: No change from before use. The numerical values in Table 7 represent the number of people, and the results are shown in Table 7.
【0052】[0052]
【表6】 [Table 6]
【0053】「試験結果」結果は表7の如く、本発明品
1〜3は、皮膚老化防止、肌荒れ、肌色共に改善され、
比較品に比べ、総合的に改善・良好な結果が得られ、有
効であることが確認出来た。"Test Results" As shown in Table 7, the products 1 to 3 of the present invention are improved in prevention of skin aging, rough skin, and complexion.
Compared to the comparative product, overall improvement and good results were obtained, confirming that it was effective.
【0054】[0054]
【表7】 [Table 7]
【0055】実施例11:安全性試験 [皮膚一次刺激性試験]クロロゲン酸を必須成分として
含有するコーヒーノキ種子抽出物(抽出例1〜3)を背
部を除毛した兎(1群3匹,体重3,800g前後)の皮膚
に貼付した。判定は貼付後24,48,72時間に一次刺激性の
評点法により紅斑及び浮腫を指標として行った。その結
果、すべての動物において、何等、紅斑及び浮腫を認め
ず陰性と判定された。 [皮膚累積刺激性試験]同様に、クロロゲン酸を必須成
分として含有するコーヒーノキ種子抽出物(抽出例1〜
3)を側腹部を除毛(2×4cm2)したハートレー系モル
モット(雌性,1群5匹,体重320g前後)の皮膚に1
日1回,週5回,0.5ml/動物当りを塗布した。塗布は
4週に渡って、又、除毛は各週の最終塗布日に行った。
判定は、各週の最終日の翌日に一次刺激性の評点法によ
り紅斑および浮腫を指標として行った。その結果、すべ
ての動物において、塗布後1〜4週目に渡って何等、紅
斑及び浮腫を認めず陰性と判定された。 [急性毒性試験]同様に、クロロゲン酸を必須成分とし
て含有するコーヒーノキ種子抽出物(抽出例1〜3)を
減圧下にて溶媒を完全に留出したものを試験前、4時間
絶食させたddy系マウス(1群5匹,体重30g)に2,000
mg/kg量経口投与し、毒性症状の発現、程度などを経時
的に観察した。その結果、すべてのマウスにおいて14日
間何等異常を認めず、解剖の結果も異常がなかった。LD
50は2,000mg/kg以上と判定された。Example 11: Safety test [Primary skin irritation test] Rabbits with coffee beans seed extracts containing chlorogenic acid as an essential component (Extraction Examples 1 to 3) having their backs dehaired (1 group, 3 animals, body weight) About 3,800 g) was applied to the skin. The evaluation was performed 24, 48, and 72 hours after application by the scoring method for primary irritation using erythema and edema as indexes. As a result, all animals were judged to be negative without any erythema or edema. [Skin cumulative irritation test] Similarly, coffee tree seed extract containing chlorogenic acid as an essential component (Extraction Examples 1 to 1)
3) 1 on the skin of Hartley guinea pigs (female, 5 animals per group, weight 320g) of which the flank was shaved (2 × 4 cm 2 ).
0.5 ml / animal was applied once a day, 5 times a week. The application was carried out for 4 weeks, and the hair removal was performed on the last application day of each week.
Judgment was performed on the day after the last day of each week, using erythema and edema as an index by the primary irritation scoring method. As a result, in all animals, erythema and edema were not observed for 1 to 4 weeks after application, and it was determined to be negative. [Acute toxicity test] Similarly, a coffee tree seed extract (extraction examples 1 to 3) containing chlorogenic acid as an essential component, in which the solvent was completely distilled off under reduced pressure, was fasted for 4 hours before the test. 2,000 per strain of mice (5 mice per group, weight 30g)
Oral administration of mg / kg was performed, and the onset and extent of toxic symptoms were observed over time. As a result, no abnormality was observed in all mice for 14 days, and there was no abnormality in the autopsy result. LD
50 was determined to be 2,000 mg / kg or more.
【0056】以下に実施例を示し、本発明の利用方法を
更に詳述するが、本発明は以下の実施例に特定されるこ
とはなく、各種の化粧品類、医薬品、医薬部外品等に含
有・配合して用いることが出来る。尚、各実施例は各製
品の製造における常法により製造したもので良く、配合
量のみを示した。The use of the present invention will be described in more detail with reference to the following examples, but the present invention is not limited to the following examples and is applicable to various cosmetics, pharmaceuticals, quasi-drugs and the like. It can be contained and compounded before use. In addition, each Example may be manufactured by a conventional method for manufacturing each product, and only the compounding amount is shown.
【0057】 実施例11:コールドクリーム 重 量% 1.サラシミツロウ 11.0 2.流動パラフィン 22.0 3.ラノリン 10.0 4.アーモンド油 15.0 5.ホウ砂 0.5 6.コーヒーノキ種子抽出液(1,3-フ゛チレンク゛リコールエキス) 3.0 7.防腐剤 適 量 8.香料 適 量 9.精製水 100とする残余Example 11: Cold Cream Weight% 1. White beeswax 11.0 2. Liquid paraffin 22.0 3. Lanolin 10.0 4. Almond oil 15.0 5. Borax 0.5 6. Coffee tree seed extract (1,3-butylene glycol extract) 3.0 7. Preservative proper amount 8. Perfume proper amount 9. Residue of purified water 100
【0058】 実施例12:クリーム 重 量% 1.スクワラン 20.0 2.ミツロウ 5.0 3.精製ホホバ油 5.0 4.グリセリンモノステアレート 2.0 5.ホ゜リオキシエチレン(20)ソルヒ゛タンモノステアレート 2.0 6.グリセリン 5.0 7.コーヒーノキ種子抽出液(30%エタノールエキス) 5.0 8.防腐剤 適 量 9.香料 適 量 10.精製水 100とする残余Example 12: Cream Weight% 1. Squalane 20.0 2. Beeswax 5.0 3. Refined jojoba oil 5.0 4. Glycerin monostearate 2.0 5. Polyoxyethylene (20) sorbitan monostearate 2.0 6. Glycerin 5.0 7. Coffee tree seed extract (30% ethanol extract) 5.0 8. Preservative proper amount 9. Suitable amount of perfume 10. Residue of purified water 100
【0059】 実施例13:ローション 重 量% 1.ソルビット 2.0 2.1,3−ブチレングリコール 2.0 3.ポリエチレングリコール1000 1.0 4.ホ゜リオキシエチレンオレイルエーテル(25E.O.) 2.0 5.エタノール 10.0 6.コーヒーノキ種子抽出液(40%フ゜ロヒ゜レンク゛リコールエキス) 5.0 7.香料 適 量 8.精製水 100とする残余Example 13: Lotion Weight% 1. Sorbit 2.0 2.1,3-butylene glycol 2.0 3. Polyethylene glycol 1000 1.0 4. Polyoxyethylene oleyl ether (25E.O.) 2.0 5. Ethanol 10.0 6. Coffee tree seed extract (40% propylene glycol extract) 5.0 7. Suitable amount of perfume 8. Residue of purified water 100
【0060】 実施例14:クリームファンデーション 重 量% 1.ステアリン酸 4.0 2.モノステアリン酸グリセリン 3.0 3.セタノール 1,5 4.ミリスチン酸イソプロピル 7.0 5.流動パラフィン 10.0 6.サラシミツロウ 3.0 8.カオリン 3.0 9.タルク 1.0 10.コーヒーノキ種子抽出液 4.0 (エタノール:1,3-フ゛チレンク゛リコール=1:1エキス) 11.着色顔料 1.0 12.トリエタノールアミン 3.0 13.グリセリン 3.0 14.ベントナイト 1.0 15.防腐剤 適 量 16.香料 適 量 17.精製水 100とする残余Example 14: Cream foundation weight% 1. Stearic acid 4.0 2. Glycerin monostearate 3.0 3. Cetanol 1,5 4. Isopropyl myristate 7.0 5. Liquid paraffin 10.0 6. White beeswax 3.0 8. Kaolin 3.0 9. Talc 1.0 10. Coffee tree seed extract 4.0 (Ethanol: 1,3-Vetylene glycol = 1: 1 extract) 11. Color pigment 1.0 12. Triethanolamine 3.0 13. Glycerin 3.0 14. Bentonite 1.0 15. Preservative proper amount 16. Suitable amount of perfume 17. Residue of purified water 100
【0061】 実施例15:シャンプー 重 量% 1.ラウリル硫酸トリエタノールアミン 5.0% 2.ホ゜リオキシエチレンラウリルエーテル硫酸ナトリウム 12.0 3.1,3−ブチレングリコール 4.0 4.ラウリン酸ジエタノールアミド 2.0 5.エデト酸二ナトリウム 0.1 6.コーヒーノキ種子抽出液(水エキス) 4.0 7.防腐剤 適 量 8.香料 適 量 9.精製水 100とする残余Example 15: Shampoo Weight% 1. Lauryl sulfate triethanolamine 5.0% 2. Sodium polyoxyethylene lauryl ether sulfate 12.0 3.1,3-butylene glycol 4.0 4. Lauric acid diethanolamide 2.0 5. Disodium edetate 0.1 6. Coffee tree seed extract (water extract) 4.0 7. Preservative proper amount 8. Perfume proper amount 9. Residue of purified water 100
【0062】 実施例16:ヘアーリキッド 重 量% 1.エタノール 25.0% 2.ホ゜リオキシフ゜ロヒ゜レンフ゛チルエーテルリン酸 12.0 3.ホ゜リオキシフ゜ロヒ゜レンモノフ゛チルエーテル 5.0 4.トリエタノールアミンルアミド 2.0 5.エデト酸二ナトリウム 0.1 6.コーヒーノキ種子抽出液(30%アセトンエキス) 4.0 7.防腐剤 適 量 8.香料 適 量 9.精製水 100とする残余Example 16: Hair Liquid Weight% 1. Ethanol 25.0% 2. Polyoxypropyl ethyl ether phosphate 12.0 3. Polyoxypropylene monobutyl ether 5.0 4. Triethanolamine ruamide 2.0 5. Disodium edetate 0.1 6. Coffee tree seed extract (30% acetone extract) 4.0 7. Preservative proper amount 8. Perfume proper amount 9. Residue of purified water 100
【0063】 実施例17:ヘアートニック 重 量% 1.エタノール 35.0% 2.オレイン酸エチル 2.0 3.ポリオキシエチレン(40)硬化ヒマシ油 2.0 4.コーヒーノキ種子抽出液(エタノールエキス) 5.0 5.香料 適 量 6.精製水 100とする残余Example 17: Heartonic Weight% 1. Ethanol 35.0% 2. Ethyl oleate 2.0 3. Polyoxyethylene (40) hydrogenated castor oil 2.0 4. Coffee tree seed extract (ethanol extract) 5.0 5. Perfume proper amount 6. Residue of purified water 100
【0064】 実施例18:浴用剤 重 量% 1.炭酸水素ナトリウム 60.0 2.無水硫酸ナトリウム 32.0 3.ホウ砂 3.0 4.コーヒーノキ種子抽出液の乾燥粉末 6.0 (エタノール:1,3-フ゛チレンク゛リコール:水=1:1:1エキス) Example 18: Bath agent Weight% 1. Sodium hydrogen carbonate 60.0 2. Anhydrous sodium sulfate 32.0 3. Borax 3.0 4. Dry powder of coffee tree seed extract 6.0 (Ethanol: 1,3-butylene glycol: water = 1: 1: 1 extract)
【0065】[0065]
【発明の効果】本発明のクロロゲン酸を必須成分として
含有するコーヒーノキ種子抽出物は、過酸化脂質生成抑
制作用、紫外線吸収作用、メラニン生成抑制作用を有す
るものであり、従って、化粧料に含有して用いれば、美
白、皮膚老化防止、毛髪保護効果が期待出来る。又、そ
の利用分野としては、医薬品・医薬部外品或は化粧品分
野(人及びその他の動物用に用いる各種製剤)の各種化
粧料用組成物が挙げられ、具体的には、ローション、乳
液、クリーム(軟膏を含む)、オイル、パック、石鹸
(薬用石鹸も含む)、ボディソープ、浴用剤、シャンプ
ー、リンス、ヘアートニック、ヘアースプレーなどへの
応用である。The coffee tree seed extract containing chlorogenic acid as an essential component of the present invention has a lipid peroxide production inhibitory action, an ultraviolet absorbing action, and a melanin production inhibitory action, and therefore is contained in cosmetics. If used, it can be expected to have a whitening effect, prevent skin aging, and protect hair. The fields of use thereof include various cosmetic compositions in the fields of pharmaceuticals / quasi-drugs or cosmetics (various preparations used for humans and other animals), specifically, lotions, emulsions, It is applied to creams (including ointments), oils, packs, soaps (including medicated soaps), body soaps, bath agents, shampoos, rinses, hairnics, hair sprays, etc.
図1は、分光光度計(1cm層長:石英セル)を用い、
吸光度測定法により紫外線の吸光度を測定したグラフで
ある。尚、検体は実施例2の抽出例1ー2を使用し、対
照としては同濃度のパラアミノ安息香酸(PABA)溶
液を用いた。1 is a spectrophotometer (1 cm layer length: quartz cell),
It is a graph which measured the light absorbency of ultraviolet rays by the light absorbency measuring method. In addition, as the sample, the extraction examples 1-2 of Example 2 were used, and as a control, a para-aminobenzoic acid (PABA) solution having the same concentration was used.
───────────────────────────────────────────────────── フロントページの続き (51)Int.Cl.6 識別記号 庁内整理番号 FI 技術表示箇所 A61K 7/42 7/50 35/78 ADA 8217−4C ADD 8217−4C ADS C 8217−4C (72)発明者 平澤 久紀 兵庫県神戸市中央区多聞通5丁目1番6号 ユーシーシーテクノデベロップメント株 式会社内 (72)発明者 岡田 忠司 愛知県一宮市北方町北方字沼田1番地 オ リザ油化株式会社内─────────────────────────────────────────────────── ─── Continuation of the front page (51) Int.Cl. 6 Identification code Internal reference number FI Technical indication location A61K 7/42 7/50 35/78 ADA 8217-4C ADD 8217-4C ADS C 8217-4C (72 ) Inventor Kuki Hirasawa 5-1-6 Tamon-dori, Chuo-ku, Kobe-shi, Hyogo UCC Techno Development Co., Ltd. In the company
Claims (3)
コーヒーノキ種子の水、低級アルコール、ポリオール系
有機溶媒から選ばれる1種又は2種以上の溶媒を用いて
得られる抽出物を配合することを特徴とする美白化粧
料。1. Containing chlorogenic acid as an essential component,
A whitening cosmetic, comprising an extract obtained by using one or more solvents selected from water, lower alcohols and polyol organic solvents of coffee tree seeds.
コーヒーノキ種子の水、低級アルコール、ポリオール系
有機溶媒から選ばれる1種又は2種以上の溶媒を用いて
得られる抽出物を配合することを特徴とする皮膚老化防
止化粧料。2. Containing chlorogenic acid as an essential component,
A skin anti-aging cosmetic composition comprising an extract obtained by using one or more solvents selected from water of coffee tree seeds, lower alcohols and polyol organic solvents.
コーヒーノキ種子の水、低級アルコール、ポリオール系
有機溶媒から選ばれる1種又は2種以上の溶媒を用いて
得られる抽出物を配合することを特徴とする毛髪保護用
化粧料。3. Containing chlorogenic acid as an essential component,
A cosmetic for protecting hair, comprising an extract obtained by using one or more solvents selected from water, lower alcohols and polyol organic solvents of coffee tree seeds.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP6248772A JPH0892057A (en) | 1994-09-16 | 1994-09-16 | Cosmetic blended with extract of seed of coffee tree |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP6248772A JPH0892057A (en) | 1994-09-16 | 1994-09-16 | Cosmetic blended with extract of seed of coffee tree |
Publications (1)
Publication Number | Publication Date |
---|---|
JPH0892057A true JPH0892057A (en) | 1996-04-09 |
Family
ID=17183159
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP6248772A Pending JPH0892057A (en) | 1994-09-16 | 1994-09-16 | Cosmetic blended with extract of seed of coffee tree |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPH0892057A (en) |
Cited By (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002060462A2 (en) * | 2001-01-30 | 2002-08-08 | Laboratórios Biosintética Ltda. | Waay to obtain a extract with antidepressant and opioid antagonists properties and pharmaceutical products obtained from it |
KR20030026959A (en) * | 2003-03-13 | 2003-04-03 | 김재필 | Soap containing coffee extract and process for producing the same |
KR100433181B1 (en) * | 1996-06-14 | 2004-08-25 | 엔 바이오 주식회사 | Antimicrobial soap composition derived from non-antibiotic containing coffee extract and egg white proteins as effective ingredient having alleviating or treating effect on symptoms of athletes foot, psoriasis, eczema and dandruff |
KR100484434B1 (en) * | 2002-05-30 | 2005-04-20 | 부산대학교 산학협력단 | Preparations for antioxidant and anti-aging comprising 3-methyl-1,2-cyclopentanedione derived from coffee |
JP2005263652A (en) * | 2004-03-17 | 2005-09-29 | Kao Corp | Skin symptom-improving agent |
JP2005350431A (en) * | 2004-06-14 | 2005-12-22 | Furabamin:Kk | Caffeine composition and its use |
JP2006306799A (en) * | 2005-04-28 | 2006-11-09 | Kao Corp | Method of producing chlorogenic acids composition |
JP2009185036A (en) * | 2004-04-08 | 2009-08-20 | Vdf Futureceuticals Inc | Coffee cherry cosmetic composition and method |
JP2013533282A (en) * | 2010-07-30 | 2013-08-22 | ネステク ソシエテ アノニム | Use of non-roasted coffee beans to regulate skin pigmentation diseases |
JP2013535461A (en) * | 2010-07-30 | 2013-09-12 | ネステク ソシエテ アノニム | Use of roasted coffee beans to regulate skin pigmentation |
JP2013537528A (en) * | 2010-07-30 | 2013-10-03 | ネステク ソシエテ アノニム | Use of a mixture of roasted and non-roasted coffee beans to control skin pigmentation |
US8597710B2 (en) | 2003-04-16 | 2013-12-03 | Vdf Futureceuticals, Inc. | Low-mycotoxin coffee cherry products |
US8603563B2 (en) | 2003-04-16 | 2013-12-10 | Vdf Futureceuticals, Inc. | Methods for coffee cherry products |
JP2015508748A (en) * | 2012-01-30 | 2015-03-23 | ユリエヴィッチ レシコフ,セルゲイ | Agents that induce the synthesis of heat shock proteins in human and animal cells; cosmetics to promote the repair process; cosmetics to reduce the side effects of invasive cosmetic procedures; dietary supplements; foodstuffs; side effects of invasive cosmetic procedures How to reduce |
JP2016196425A (en) * | 2015-04-03 | 2016-11-24 | ホーユー株式会社 | Hair cosmetic composition |
WO2020067061A1 (en) * | 2018-09-28 | 2020-04-02 | 株式会社村田製作所 | Electromagnetic wave absorber, sunscreen, optical component, eyeglasses, and method for producing electromagnetic wave absorber |
JP2020105161A (en) * | 2018-12-27 | 2020-07-09 | ロート製薬株式会社 | Dkk1 production promoter and method for producing the same, beauty composition for promoting dkk1 production and method for producing the same, as well as dkk1 production promotion method |
CN117137835A (en) * | 2023-04-25 | 2023-12-01 | 广州君奕科技有限公司 | Alopecia preventing composition, daily chemical product and application |
-
1994
- 1994-09-16 JP JP6248772A patent/JPH0892057A/en active Pending
Cited By (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100433181B1 (en) * | 1996-06-14 | 2004-08-25 | 엔 바이오 주식회사 | Antimicrobial soap composition derived from non-antibiotic containing coffee extract and egg white proteins as effective ingredient having alleviating or treating effect on symptoms of athletes foot, psoriasis, eczema and dandruff |
WO2002060462A2 (en) * | 2001-01-30 | 2002-08-08 | Laboratórios Biosintética Ltda. | Waay to obtain a extract with antidepressant and opioid antagonists properties and pharmaceutical products obtained from it |
WO2002060462A3 (en) * | 2001-01-30 | 2002-12-19 | Laboratorios Biosintetica Ltda | Waay to obtain a extract with antidepressant and opioid antagonists properties and pharmaceutical products obtained from it |
KR100484434B1 (en) * | 2002-05-30 | 2005-04-20 | 부산대학교 산학협력단 | Preparations for antioxidant and anti-aging comprising 3-methyl-1,2-cyclopentanedione derived from coffee |
KR20030026959A (en) * | 2003-03-13 | 2003-04-03 | 김재필 | Soap containing coffee extract and process for producing the same |
US9930900B2 (en) | 2003-04-16 | 2018-04-03 | Vdf Futureceuticals, Inc. | Low-mycotoxin coffee cherry products |
US8597710B2 (en) | 2003-04-16 | 2013-12-03 | Vdf Futureceuticals, Inc. | Low-mycotoxin coffee cherry products |
US10238128B2 (en) | 2003-04-16 | 2019-03-26 | Vdf Futureceuticals, Inc. | Low-mycotoxin coffee cherry products |
US9888702B2 (en) | 2003-04-16 | 2018-02-13 | Vdf Futureceuticals | Low-mycotoxin coffee cherry products |
US8603564B2 (en) | 2003-04-16 | 2013-12-10 | Vdf Futureceuticals, Inc. | Low-mycotoxin coffee cherry products |
US8603563B2 (en) | 2003-04-16 | 2013-12-10 | Vdf Futureceuticals, Inc. | Methods for coffee cherry products |
JP2005263652A (en) * | 2004-03-17 | 2005-09-29 | Kao Corp | Skin symptom-improving agent |
JP2009185036A (en) * | 2004-04-08 | 2009-08-20 | Vdf Futureceuticals Inc | Coffee cherry cosmetic composition and method |
US10653614B2 (en) | 2004-04-08 | 2020-05-19 | Vdf Futureceuticals, Inc. | Coffee cherry cosmetic composition and methods |
JP2005350431A (en) * | 2004-06-14 | 2005-12-22 | Furabamin:Kk | Caffeine composition and its use |
JP2006306799A (en) * | 2005-04-28 | 2006-11-09 | Kao Corp | Method of producing chlorogenic acids composition |
JP2013537528A (en) * | 2010-07-30 | 2013-10-03 | ネステク ソシエテ アノニム | Use of a mixture of roasted and non-roasted coffee beans to control skin pigmentation |
JP2013535461A (en) * | 2010-07-30 | 2013-09-12 | ネステク ソシエテ アノニム | Use of roasted coffee beans to regulate skin pigmentation |
JP2013533282A (en) * | 2010-07-30 | 2013-08-22 | ネステク ソシエテ アノニム | Use of non-roasted coffee beans to regulate skin pigmentation diseases |
JP2015508748A (en) * | 2012-01-30 | 2015-03-23 | ユリエヴィッチ レシコフ,セルゲイ | Agents that induce the synthesis of heat shock proteins in human and animal cells; cosmetics to promote the repair process; cosmetics to reduce the side effects of invasive cosmetic procedures; dietary supplements; foodstuffs; side effects of invasive cosmetic procedures How to reduce |
JP2016196425A (en) * | 2015-04-03 | 2016-11-24 | ホーユー株式会社 | Hair cosmetic composition |
WO2020067061A1 (en) * | 2018-09-28 | 2020-04-02 | 株式会社村田製作所 | Electromagnetic wave absorber, sunscreen, optical component, eyeglasses, and method for producing electromagnetic wave absorber |
JP2020105161A (en) * | 2018-12-27 | 2020-07-09 | ロート製薬株式会社 | Dkk1 production promoter and method for producing the same, beauty composition for promoting dkk1 production and method for producing the same, as well as dkk1 production promotion method |
CN117137835A (en) * | 2023-04-25 | 2023-12-01 | 广州君奕科技有限公司 | Alopecia preventing composition, daily chemical product and application |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2858961B2 (en) | Cosmetic or pharmaceutical composition containing mangiferin or its derivative as active ingredient in pure form or as plant extract | |
JP3499616B2 (en) | Application to hydroxytyrosol, melanin production inhibitor or lipid peroxide production inhibitor | |
JPH0892057A (en) | Cosmetic blended with extract of seed of coffee tree | |
WO2001026670A1 (en) | Skin-care agents, skin antiaging agents, whitening agents and external skin preparations | |
KR102142311B1 (en) | Skin external composition comprising tangeretin | |
KR100992088B1 (en) | Cosmetic composition containing natural plant extracts with x-ray protecting effect | |
JPH0826967A (en) | Cosmetic containing chlorogenic acid or its derivative | |
JP2001335499A (en) | Cosmetic composition | |
KR102525467B1 (en) | Skin external application composition for anti-aging containing Rhodotypos scandens extract | |
KR101744889B1 (en) | Composition for Anti-oxidation, Whitening and Wrinkles protection | |
KR101870377B1 (en) | Cosmetic composition for improving moisturizing and antioxidant containing ultrasonicating extract of cucumber seed | |
KR102226179B1 (en) | Cosmetic Compositions for Anti-aging Comprising Extracts of Plants | |
KR102711814B1 (en) | Skin external application composition for anti-aging | |
KR100926073B1 (en) | The skin beautifing cosmetic composition containing vitamin C and the extract of Opuntia ficus-indica L. var. saboten Makino flowers | |
JP2011195539A (en) | Elastase activity inhibitor | |
JP2002370962A (en) | Bleaching preparation and cosmetic for preventing and improving aging of skin | |
KR20180137151A (en) | Cosmetic composition for preventing photo aging comprising Curcuma longa Linne leaf and Hibiscus manihot extracts | |
KR101500551B1 (en) | Cosmetic composition with hydroxycitric acid for skin whitening | |
JPH0672838A (en) | Cosmetic | |
JP2000096050A (en) | Promoter for production of hyaluronic acid | |
KR20070111025A (en) | Anti-wrinkle cosmetic compositions comprising the extract of phaseolus radiatus as active ingredient | |
CN109745262A (en) | A kind of composition for Whitening, spot face cream | |
KR20200073523A (en) | Cosmetic Composition for Improving Skin Wrinkle Contaning the Extract of Lithospermum Erythrorhizon | |
KR20200048225A (en) | The obtaining method of compound | |
KR102718114B1 (en) | Composition for inhibiting body odor, serum secretion, and dandruff comprising Lagerstroemia indica extracts as an active ingredient |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20031111 |